<code id='82F5C62AC8'></code><style id='82F5C62AC8'></style>
    • <acronym id='82F5C62AC8'></acronym>
      <center id='82F5C62AC8'><center id='82F5C62AC8'><tfoot id='82F5C62AC8'></tfoot></center><abbr id='82F5C62AC8'><dir id='82F5C62AC8'><tfoot id='82F5C62AC8'></tfoot><noframes id='82F5C62AC8'>

    • <optgroup id='82F5C62AC8'><strike id='82F5C62AC8'><sup id='82F5C62AC8'></sup></strike><code id='82F5C62AC8'></code></optgroup>
        1. <b id='82F5C62AC8'><label id='82F5C62AC8'><select id='82F5C62AC8'><dt id='82F5C62AC8'><span id='82F5C62AC8'></span></dt></select></label></b><u id='82F5C62AC8'></u>
          <i id='82F5C62AC8'><strike id='82F5C62AC8'><tt id='82F5C62AC8'><pre id='82F5C62AC8'></pre></tt></strike></i>

          Home / entertainment / leisure time

          leisure time


          leisure time

          author:hotspot    Page View:961
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In